The FDA releases a pair of draft guidances to help medical device makers navigate communication via character-constrained online channels and respond to misinformation.
FDA regulators published a pair of new draft guidances this week to provide clarity on its stance regarding online communication in challenging situations, especially via character-constrained channels such as Twitter or when responding to misinformation posted online.
from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1uFCdSl
Cap comentari:
Publica un comentari a l'entrada